Mark Atkins

3.7k total citations
52 papers, 2.7k citations indexed

About

Mark Atkins is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mark Atkins has authored 52 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 23 papers in Hepatology and 20 papers in Infectious Diseases. Recurrent topics in Mark Atkins's work include Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (21 papers) and HIV Research and Treatment (10 papers). Mark Atkins is often cited by papers focused on Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (21 papers) and HIV Research and Treatment (10 papers). Mark Atkins collaborates with scholars based in United Kingdom, United States and China. Mark Atkins's co-authors include Rong‐Nan Chien, Yun‐Fan Liaw, Ching‐Lung Lai, Mary Woessner, Jules L. Dienstag, Nathaniel Brown, Eugene R. Schiff, Mark Nelson, Lynn D. Condreay and Richard Boehme and has published in prestigious journals such as The Lancet, Blood and Annals of Internal Medicine.

In The Last Decade

Mark Atkins

52 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Atkins United Kingdom 22 2.2k 1.9k 777 185 154 52 2.7k
Ignacio de los Santos Spain 25 950 0.4× 826 0.4× 777 1.0× 90 0.5× 54 0.4× 117 1.7k
Thierry May France 21 976 0.5× 396 0.2× 757 1.0× 428 2.3× 29 0.2× 40 1.8k
Michele Soares Gomes‐Gouvêa Brazil 21 758 0.4× 714 0.4× 632 0.8× 119 0.6× 27 0.2× 78 1.6k
G. Lunghi Italy 31 2.1k 1.0× 2.1k 1.1× 655 0.8× 100 0.5× 23 0.1× 145 2.9k
G Raguin France 18 710 0.3× 557 0.3× 540 0.7× 119 0.6× 291 1.9× 75 2.0k
Mojca Matičič Slovenia 17 781 0.4× 592 0.3× 491 0.6× 159 0.9× 30 0.2× 81 1.4k
Maria Dorrucci Italy 26 923 0.4× 350 0.2× 1.1k 1.4× 396 2.1× 72 0.5× 67 2.1k
Juan González‐García Spain 27 1.9k 0.9× 1.7k 0.9× 1.7k 2.2× 50 0.3× 78 0.5× 165 3.5k
Patrick Miailhes France 24 995 0.5× 862 0.4× 383 0.5× 28 0.2× 61 0.4× 82 1.4k
Alessandro Cozzi Lepri Italy 25 662 0.3× 239 0.1× 1.1k 1.5× 73 0.4× 33 0.2× 70 2.0k

Countries citing papers authored by Mark Atkins

Since Specialization
Citations

This map shows the geographic impact of Mark Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Atkins more than expected).

Fields of papers citing papers by Mark Atkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Atkins. The network helps show where Mark Atkins may publish in the future.

Co-authorship network of co-authors of Mark Atkins

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Atkins. A scholar is included among the top collaborators of Mark Atkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Atkins. Mark Atkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanson, Heidi A., William W. Hay, Jonathan N. Tobin, et al.. (2018). Opportunities for life course research through the integration of data across Clinical and Translational Research Institutes. Journal of Clinical and Translational Science. 2(3). 156–162. 2 indexed citations
2.
Beloukas, Apostolos, Simon King, Mark Hopkins, et al.. (2015). Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in hepatitis C virus genotype 1a strains in the UK. Clinical Microbiology and Infection. 21(11). 1033–1039. 19 indexed citations
3.
Drumright, Lydia N., Simon D. W. Frost, Alex J. Elliot, et al.. (2015). Assessing the use of hospital staff influenza-like absence (ILA) for enhancing hospital preparedness and national surveillance. BMC Infectious Diseases. 15(1). 110–110. 8 indexed citations
4.
Thornton, Alicia, Michael Rayment, Gillian Elam, et al.. (2012). Exploring staff attitudes to routine HIV testing in non-traditional settings: a qualitative study in four healthcare facilities. Sexually Transmitted Infections. 88(8). 601–606. 33 indexed citations
6.
Singh, Gurmit, Samreen Ijaz, Neesha Rockwood, et al.. (2011). Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV. Journal of Infection. 66(1). 103–106. 67 indexed citations
7.
Scott, Christopher, et al.. (2010). Unselected hepatitis C screening of men who have sex with men attending sexual health clinics. Journal of Infection. 60(5). 351–353. 23 indexed citations
8.
Annear, Nicholas M. P., H. Terence Cook, Mark Atkins, Charles D. Pusey, & Alan D. Salama. (2009). Non–hepatitis virus associated mixed essential cryoglobulinemia. Kidney International. 77(2). 161–164. 8 indexed citations
9.
Coyne, Katherine, John Parry, Mark Atkins, Anton Pozniak, & Alan McOwan. (2007). Spontaneous HIV-1 Seroreversion in an Adult Male. Sexually Transmitted Diseases. 34(9). 627–630. 6 indexed citations
10.
D’Antiga, Lorenzo, Marion Aw, Mark Atkins, et al.. (2006). Combined lamivudine/interferon-α treatment in ‘immunotolerant’ children perinatally infected with hepatitis B: A pilot study. The Journal of Pediatrics. 148(2). 228–233.e1. 73 indexed citations
11.
Gilleece, Yvonne, David Asboe, Mark Atkins, et al.. (2005). Transmission of Hepatitis C Virus Among HIV-Positive Homosexual Men and Response to a 24-Week Course of Pegylated Interferon and Ribavirin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(1). 41–46. 100 indexed citations
12.
Atkins, Mark, et al.. (2005). Sexual transmission of hepatitis B. Current Opinion in Infectious Diseases. 18(1). 67–72. 21 indexed citations
13.
Lai, Ching‐Lung, Jules L. Dienstag, Eugene R. Schiff, et al.. (2003). Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B. Clinical Infectious Diseases. 36(6). 687–696. 497 indexed citations
14.
Pillay, Deenan, Patricia A. Cane, Daina Ratcliffe, Mark Atkins, & David A. Cooper. (2000). Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. AIDS. 14(9). 1111–1116. 37 indexed citations
15.
Dore, Gregory J., David A. Cooper, Catherine Barrett, et al.. (1999). Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Persons in a Randomized, Controlled Study (CAESAR). The Journal of Infectious Diseases. 180(3). 607–613. 123 indexed citations
16.
Atkins, Mark, Nathaniel Brown, Mary Woessner, et al.. (1998). Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients.. UCL Discovery (University College London). 13 indexed citations
17.
Sullivan, Ann, Mark Atkins, & F Boag. (1997). Factors Facilitating the Sexual Transmission of HIV-1. AIDS Patient Care and STDs. 11(3). 167–177. 2 indexed citations
18.
Atkins, Mark, E M Carlin, Vincent C. Emery, Paul Griffiths, & F Boag. (1996). Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases: Fig 1. BMJ. 313(7053). 341–342. 58 indexed citations
19.
Atkins, Mark, et al.. (1991). Environmental contamination during tracheal suction. Anaesthesia. 46(11). 957–961. 66 indexed citations
20.
Atkins, Mark, et al.. (1990). Pseudomonas aeruginosa orbital cellulitis in four neutropenic patients. Journal of Hospital Infection. 16(4). 343–349. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026